Cost-Effectiveness Of Once Daily Dolutegravir Versus Twice Daily Raltegravir As First-Line Antiretroviral Therapy In Hiv-Infected Adults In The United States
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1595
https://www.valueinhealthjournal.com/article/S1098-3015(14)01646-5/fulltext
Title :
Cost-Effectiveness Of Once Daily Dolutegravir Versus Twice Daily Raltegravir As First-Line Antiretroviral Therapy In Hiv-Infected Adults In The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01646-5&doi=10.1016/j.jval.2014.03.1595
First page :
A274
Section Title :
Infection
Open access? :
No
Section Order :
1083